Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-03
1992-07-07
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 70, C07D47104, C07D22118, A61K 31435
Patent
active
051283450
ABSTRACT:
Novel indoloquinoline compounds of formula (I), benzo(b)acridines of formula (II) and benzo(c)acridines of formula (III) have carcinostatic activities. The compounds, processes for preparing the compounds via nucleophilic aromatic substitution, and carcinostatic compositions containing the same are disclosed. ##STR1##
REFERENCES:
patent: 4826850 (1989-05-01), Yamato
Merck Manual, [Rahway, N.J. Merck and Co. 1987], pp. 2306 to 2309.
Yamato et al., J. Med. Chem., vol. 32, No. 6, pp. 1295-3000 (1989).
Atwell et al., J. Med. Chem., vol. 15 (6), pp. 611-615 (1972).
Cain et al., J. Med. Chem., vol. 17 (9), pp. 422-430 (1974).
Cain et al., J. Med. Chem., vol. 18 (11), pp. 3881-3884 (1979).
Van Echo et al., Canc. Res. 39, pp. 3881-3884 (Oct. 1979).
Dziewonski et al., Chem. Abs., vol. 59 (10), entry 11365d (1963).
Bond Robert T.
Mect Corporation
Ward Edward C.
LandOfFree
Carcinostatic composition comprising indolquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carcinostatic composition comprising indolquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carcinostatic composition comprising indolquinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1829983